Form UPLOAD - SEC-generated letter:
SEC Accession No. 0000000000-17-001376
Filing Date
2017-01-13
Accepted
2017-01-13 09:45:06
Documents
1

Document Format Files

Seq Description Document Type Size
1 filename1.pdf LETTER 101807
  Complete submission text file 0000000000-17-001376.txt   141261
Mailing Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010
Business Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010 (212) 994-8200
Protagenic Therapeutics, Inc.\new (Filed for) CIK: 0001022899 (see all company filings)

EIN.: 061390025 | State of Incorp.: DE | Fiscal Year End: 1231
Type: UPLOAD
SIC: 7389 Services-Business Services, NEC